We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore Medicare coverage for Xifaxan (rifaximin), a key medication for IBS-D and hepatic encephalopathy. Learn about Part D plans, formularies, costs, prior authorization, and financial assistance options to manage your prescription drug expenses.

Montek LC tablet is applied in the treatment of allergies and asthma symptoms. This is an instructional manual on the usage, benefits, dosage and precautions to treat it safely and effectively.
April 11, 2026

Cyclopam tablet is commonly used for abdominal pain and cramps. This guide explains its uses, benefits, dosage, and safety precautions for effective relief.
April 11, 2026

Navigating the complexities of Medicare coverage for prescription medications can be a daunting task, especially when dealing with specific drugs like Xifaxan (rifaximin). Xifaxan is a vital medication for several gastrointestinal conditions, and understanding how Medicare plans address its coverage is crucial for beneficiaries. This comprehensive guide will delve into what Xifaxan is, how Medicare works, and the specifics of obtaining coverage for Xifaxan, helping you make informed decisions about your healthcare.
Xifaxan, with the generic name rifaximin, is a non-systemic antibiotic that works primarily in the gut. Unlike many antibiotics that are absorbed into the bloodstream, rifaximin stays largely within the gastrointestinal tract, targeting bacteria locally. This localized action minimizes systemic side effects and makes it particularly effective for conditions rooted in gut flora imbalances.
As a rifamycin-class antibiotic, rifaximin inhibits bacterial RNA synthesis, effectively stopping the growth of susceptible bacteria. Because it is poorly absorbed, it achieves high concentrations within the gastrointestinal tract, making it an excellent choice for treating localized bacterial overgrowth or infections without significantly affecting the body's overall microbial balance outside the gut.
Medicare is the federal health insurance program for people 65 or older, certain younger people with disabilities, and people with End-Stage Renal Disease (ESRD). It is divided into several parts, each covering different services.
Since Xifaxan is a prescription medication you typically take at home, its coverage primarily falls under Medicare Part D. Here’s what you need to know about Part D:
The short answer is: Yes, Medicare Part D plans generally cover Xifaxan, but the extent of coverage and your out-of-pocket costs will vary significantly depending on your specific Part D plan.
Several factors determine whether your Medicare Part D plan will cover Xifaxan and what you'll pay:
The most critical factor is whether Xifaxan is included in your plan's formulary. While most formularies include a wide range of commonly prescribed drugs, specific brand-name drugs like Xifaxan may not be covered by every plan or might be placed on a higher tier, leading to higher costs.
Formularies categorize drugs into different tiers, each with a different cost-sharing level. Generic drugs are typically in lower tiers (Tier 1 or 2) with the lowest copayments. Brand-name drugs, especially specialty medications, are often in higher tiers (Tier 3, 4, or Specialty Tier), which entail higher copayments or coinsurance.
Many Part D plans require prior authorization for high-cost or specialty medications like Xifaxan. This means your doctor must submit a request and provide documentation to your plan, explaining why Xifaxan is medically necessary for your condition. The plan reviews this information to decide if they will cover the drug. Common reasons for PA include:
Some plans may implement step therapy requirements. Under step therapy, you might be required to try a less expensive, often generic, alternative medication first. If that medication is ineffective or causes unacceptable side effects, your plan may then cover Xifaxan. Your doctor would need to document the failure of the alternative treatment.
Part D plans may impose quantity limits on Xifaxan, restricting the amount of medication you can receive per refill or within a specific timeframe. This is often done to ensure appropriate use and prevent waste.
Medicare Part D plans generally only cover drugs for medically necessary and FDA-approved uses. If your doctor prescribes Xifaxan for an “off-label” use (a use not officially approved by the FDA), your plan may deny coverage. Your doctor might be able to appeal this decision with strong medical justification, but it's not guaranteed.
Even with Medicare Part D coverage, you will likely have out-of-pocket costs for Xifaxan. These costs can include:
Without insurance, Xifaxan can be very expensive, often costing hundreds or even thousands of dollars for a single course of treatment, depending on the dosage and quantity.
Given the variability, it is essential to verify your specific plan's coverage for Xifaxan. Here’s how:
The official Medicare Plan Finder tool on Medicare.gov allows you to compare Part D plans available in your area. You can enter your current medications (including Xifaxan) to see which plans cover them and estimate your out-of-pocket costs for the year.
Each Part D plan provides a copy of its formulary. You can usually find this document on your plan's website or request a hard copy. Look for Xifaxan (rifaximin) to see if it's covered and what tier it's on.
Call the member services number on your insurance card. A representative can provide the most accurate and up-to-date information regarding Xifaxan coverage, including any prior authorization, step therapy, or quantity limit requirements, and your estimated costs.
Discuss your concerns with your prescribing physician. They can help you understand the medical necessity of Xifaxan and can assist with prior authorization requests or appeals if needed. They may also be aware of alternative treatments or financial assistance programs.
If the cost of Xifaxan under your Medicare plan is prohibitive, several programs may offer financial assistance:
If Xifaxan is not covered by your plan, or if the out-of-pocket costs remain too high, discuss alternative treatment options with your doctor.
Always consult your doctor before making any changes to your medication regimen or exploring alternative treatments.
You should consult your doctor if you experience symptoms consistent with IBS-D, hepatic encephalopathy, or severe traveler's diarrhea. Early diagnosis and appropriate treatment are crucial for managing these conditions effectively. Furthermore, if you are currently taking Xifaxan and have concerns about its effectiveness, side effects, or Medicare coverage, schedule an appointment to discuss these issues with your healthcare provider. They can help you navigate treatment options and understand your insurance benefits.
Xifaxan is the brand name for the drug rifaximin. While generic rifaximin is available in some formulations and countries, the branded Xifaxan is widely prescribed in the U.S. and often subject to higher costs and specific coverage rules.
Generally, no. Medicare Part B covers drugs administered in a doctor's office or hospital outpatient setting (e.g., injections, infusions) or certain durable medical equipment. Xifaxan is typically a self-administered oral medication, so it falls under Medicare Part D prescription drug coverage.
If your doctor prescribes Xifaxan for an off-label use (a condition not specifically approved by the FDA), your Medicare Part D plan may deny coverage. Your doctor can appeal this decision by providing strong medical justification and documentation, but coverage is not guaranteed.
Medicare Part D plans review and update their formularies annually, typically before the Annual Enrollment Period (October 15 - December 7) for the upcoming year. Plans can also make changes during the year, but they must notify members of any changes that affect drugs they are currently taking.
Without insurance, a typical course of Xifaxan can be very expensive, ranging from several hundred to over a thousand dollars, depending on the dosage, quantity, and pharmacy. This highlights the importance of understanding your Medicare Part D coverage or exploring patient assistance programs.
Xifaxan is a critical medication for managing conditions like IBS-D and hepatic encephalopathy. While Medicare Part D plans generally offer coverage for Xifaxan, the specifics of that coverage, including formulary placement, prior authorization requirements, and out-of-pocket costs, vary significantly between plans. It is crucial for Medicare beneficiaries to proactively research their specific Part D plan, communicate openly with their healthcare provider, and explore available financial assistance programs to ensure access to this important treatment. By understanding the intricacies of your Medicare benefits, you can better manage your health and medication expenses.
Zincovit tablet is a multivitamin supplement that supports immunity and overall health. This guide explains its uses, benefits, dosage, and safety precautions for proper use.
April 11, 2026